Literature DB >> 18470729

Prion protein immunohistochemistry in Creutzfeldt-Jakob disease.

G Gkovács1, K Majtényi, L László.   

Abstract

Creutzfeldt-Jakob disease is a transmissible spongiform encephalopathy characterized clinically by dementia, myoclonus and, in some cases, periodic triphasic EEG-patterns. Neuropathologically the main features are spongiform change, astrocytosis, neuronal cell loss and, in a small percent of cases, amyloid plaques. Prion protein immunohistochemistry is used for definitive diagnosis of these diseases. In our study we present different immunostaining patterns in light microscopy using anti prion protein, and with immunogold labelling for ultrastructural localization of prion protein. Our results demonstrate the clinicopathological heterogeneity of Creutzfeldt-Jakob disease and reveal the role of the endosomal-lysosomal system in the pathogenesis.

Entities:  

Year:  1997        PMID: 18470729     DOI: 10.1007/BF02899920

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  16 in total

Review 1.  Multiple roles for PrP in the prion diseases.

Authors:  J P Estibeiro
Journal:  Trends Neurosci       Date:  1996-07       Impact factor: 13.837

2.  Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease.

Authors:  P Parchi; R Castellani; S Capellari; B Ghetti; K Young; S G Chen; M Farlow; D W Dickson; A A Sima; J Q Trojanowski; R B Petersen; P Gambetti
Journal:  Ann Neurol       Date:  1996-06       Impact factor: 10.422

3.  Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD.

Authors:  J Collinge; K C Sidle; J Meads; J Ironside; A F Hill
Journal:  Nature       Date:  1996-10-24       Impact factor: 49.962

4.  Prion protein genotype and pathological phenotype studies in sporadic Creutzfeldt-Jakob disease.

Authors:  S T MacDonald; K Sutherland; J W Ironside
Journal:  Neuropathol Appl Neurobiol       Date:  1996-08       Impact factor: 8.090

Review 5.  Molecular biology and pathogenesis of prion diseases.

Authors:  S B Prusiner
Journal:  Trends Biochem Sci       Date:  1996-12       Impact factor: 13.807

6.  Neuropathological diagnostic criteria for Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (prion diseases).

Authors:  H Budka; A Aguzzi; P Brown; J M Brucher; O Bugiani; F Gullotta; M Haltia; J J Hauw; J W Ironside; K Jellinger
Journal:  Brain Pathol       Date:  1995-10       Impact factor: 6.508

7.  Lysosomes as key organelles in the pathogenesis of prion encephalopathies.

Authors:  L Laszlo; J Lowe; T Self; N Kenward; M Landon; T McBride; C Farquhar; I McConnell; J Brown; J Hope
Journal:  J Pathol       Date:  1992-04       Impact factor: 7.996

Review 8.  Human prion diseases.

Authors:  S B Prusiner; K K Hsiao
Journal:  Ann Neurol       Date:  1994-04       Impact factor: 10.422

9.  A new variant of Creutzfeldt-Jakob disease in the UK.

Authors:  R G Will; J W Ironside; M Zeidler; S N Cousens; K Estibeiro; A Alperovitch; S Poser; M Pocchiari; A Hofman; P G Smith
Journal:  Lancet       Date:  1996-04-06       Impact factor: 79.321

10.  Rapid detection of Creutzfeldt-Jakob disease and scrapie prion proteins.

Authors:  D Serban; A Taraboulos; S J DeArmond; S B Prusiner
Journal:  Neurology       Date:  1990-01       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.